Association between antithrombotic agents use and hepatocellular carcinoma risk: a two-sample mendelian randomization analysis

Fengyi Yang,Ouyang Li,Benjian Gao,Zhuo Chen,Bo Li,Jiaqi He,Xiaoli Yang
DOI: https://doi.org/10.1007/s00432-024-05960-7
2024-10-23
Journal of Cancer Research and Clinical Oncology
Abstract:Hepatocellular carcinoma (HCC) is the most common primary liver cancer worldwide. Multiple observational studies demonstrated a negative association between the use of antithrombotic agents and the risk of HCC. However, the precise causal relationship between these factors remains uncertain. Therefore, our study used a two-sample Mendelian randomization (MR) analysis to assess the causal link between these two factors.
oncology
What problem does this paper attempt to address?